Combination of P2Y6 inhibitors and immune checkpoint inhibitors Vlaams Instituut voor Biotechnologie
The invention is situated in the field of cancer treatment. In particular it relates to treatments comprising combining a P2Y6 inhibitor and an immune checkpoint inhibitor. Further in particular, the treatment is of benefit for cancers poorly responding to immune checkpoint inhibitor therapy.